Currently, Gossamer Bio Inc [GOSS] is trading at $2.38, down -0.42%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GOSS shares have gain 9.17% over the last week, with a monthly amount drifted -15.60%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gossamer Bio Inc [NASDAQ: GOSS] stock has seen the most recent analyst activity on September 10, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $9 for it. Previously, Scotiabank started tracking the stock with Sector Outperform rating on July 14, 2025, and set its price target to $11. On June 25, 2024, Oppenheimer initiated with a Outperform rating and assigned a price target of $9 on the stock. UBS downgraded its rating to a Neutral and reduced its price target to $1.25 on July 27, 2023. Raymond James downgraded its rating to Mkt Perform for this stock on March 07, 2023. In a note dated March 01, 2023, Guggenheim initiated an Neutral rating.
This stock has fluctuated between a low of $0.66 and a high of $3.60 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Gossamer Bio Inc [NASDAQ: GOSS] shares were valued at $2.38 at the most recent close of the market. An investor can expect a potential return of 278.15% based on the average GOSS price forecast.
Analyzing the GOSS fundamentals
Trailing Twelve Months sales for Gossamer Bio Inc [NASDAQ:GOSS] were 40.24M which represents -88.01% decline. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -3.62%, Pretax Profit Margin comes in at -3.54%, and Net Profit Margin reading is -3.45%. To continue investigating profitability, this company’s Return on Assets is posted at -0.58, Equity is -17.75 and Total Capital is -0.78. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-4.4.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.31 points at the first support level, and at 2.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.43, and for the 2nd resistance point, it is at 2.47.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Gossamer Bio Inc [NASDAQ:GOSS] is 4.40. In addition, the Quick Ratio stands at 4.40 and the Cash Ratio stands at 0.49. Considering the valuation of this stock, the price to sales ratio is 13.45.
Transactions by insiders
Recent insider trading involved Milligan Sandra, Director, that happened on Aug 19 ’25 when 26050.0 shares were purchased.
